Total Payments
$1,132
2024 Payments
$89.11
Companies
23
Transactions
43
Medicare Patients
1,754
Medicare Billing
$218,547
Payment Breakdown by Category
Food & Beverage$770.20 (68.0%)
Education$362.07 (32.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $770.20 | 34 | 68.0% |
| Education | $362.07 | 9 | 32.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $174.94 | 2 | $0 (2022) |
| Gilead Sciences, Inc. | $136.92 | 2 | $0 (2021) |
| Incyte Corporation | $112.76 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $93.85 | 6 | $0 (2022) |
| GENZYME CORPORATION | $89.11 | 1 | $0 (2024) |
| TESARO, Inc. | $75.45 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $47.95 | 3 | $0 (2018) |
| PFIZER INC. | $47.03 | 3 | $0 (2018) |
| Genentech USA, Inc. | $35.72 | 2 | $0 (2018) |
| Celgene Corporation | $34.57 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89.11 | 1 | GENZYME CORPORATION ($89.11) |
| 2023 | $78.55 | 3 | Astellas Pharma US Inc ($32.92) |
| 2022 | $115.29 | 2 | SANOFI-AVENTIS U.S. LLC ($99.95) |
| 2021 | $23.89 | 2 | Acrotech Biopharma LLC ($11.97) |
| 2020 | $16.57 | 1 | E.R. Squibb & Sons, L.L.C. ($16.57) |
| 2019 | $224.95 | 2 | Gilead Sciences, Inc. ($125.00) |
| 2018 | $382.62 | 23 | TESARO, Inc. ($48.92) |
| 2017 | $201.29 | 9 | SANOFI-AVENTIS U.S. LLC ($74.99) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $89.11 | General |
| Category: Oncology | ||||||
| 09/12/2023 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Oncology | ||||||
| 08/22/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Oncology | ||||||
| 08/01/2023 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Oncology | ||||||
| 10/26/2022 | SANOFI-AVENTIS U.S. LLC | ELITEK (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 02/07/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | In-kind items and services | $15.34 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 04/06/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $11.97 | General |
| Category: ONCOLOGY | ||||||
| 07/27/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $16.57 | General |
| Category: Oncology | ||||||
| 06/04/2019 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.95 | General |
| 05/17/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 11/30/2018 | Abbott Laboratories | Epic Stented Tissue Valve (Device) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 06/19/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Hematology / Oncology | ||||||
| 06/14/2018 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug) | Education | In-kind items and services | $15.14 | General |
| Category: PARENTERAL IRON REPLACEMENT | ||||||
| 06/13/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Oncology | ||||||
| 05/30/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Oncology | ||||||
| 05/08/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/27/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2018 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Oncology | ||||||
| 04/24/2018 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Oncology | ||||||
| 04/19/2018 | E.R. Squibb & Sons, L.L.C. | SPRYCEL (Drug) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: Oncology | ||||||
| 04/18/2018 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $12.81 | General |
| Category: Hematology/Oncology | ||||||
| 04/10/2018 | Taiho Oncology, Inc. | Lonsurf (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Oncology | ||||||
| 03/29/2018 | Amgen Inc. | Aranesp (Biological), Nplate, Prolia | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 325 | 631 | $129,622 | $43,973 |
| 2022 | 8 | 412 | 769 | $161,529 | $57,139 |
| 2021 | 9 | 468 | 813 | $157,664 | $61,527 |
| 2020 | 11 | 549 | 934 | $179,339 | $55,908 |
Total Patients
1,754
Total Services
3,147
Medicare Billing
$218,547
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 436 | $87,134 | $29,337 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 73 | $19,578 | $7,489 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 84 | $11,712 | $3,951 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,501 | $1,287 | 28.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $4,439 | $1,220 | 27.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,258 | $687.72 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 473 | $90,038 | $31,477 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 74 | 169 | $43,046 | $17,209 | 40.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $7,803 | $2,401 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 55 | $7,086 | $1,906 | 26.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $4,560 | $1,436 | 31.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 18 | $3,106 | $979.97 | 31.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 13 | $3,238 | $978.22 | 30.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $2,652 | $751.62 | 28.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 212 | 422 | $75,684 | $28,794 | 38.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 59 | 155 | $37,397 | $16,479 | 44.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 88 | 112 | $13,746 | $5,137 | 37.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 25 | 25 | $5,683 | $3,147 | 55.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $8,476 | $2,758 | 32.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 36 | $6,049 | $1,980 | 32.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 13 | $4,055 | $1,348 | 33.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 17 | $4,063 | $1,345 | 33.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 15 | $2,511 | $538.83 | 21.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 197 | 417 | $78,445 | $22,907 | 29.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 63 | 134 | $35,278 | $10,587 | 30.0% |
About Dr. Young Choi, MD
Dr. Young Choi, MD is a Hematology & Oncology healthcare provider based in Racine, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1871712083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Young Choi, MD has received a total of $1,132 in payments from pharmaceutical and medical device companies, with $89.11 received in 2024. These payments were reported across 43 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($770.20).
As a Medicare-enrolled provider, Choi has provided services to 1,754 Medicare beneficiaries, totaling 3,147 services with total Medicare billing of $218,547. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Racine, WI
- Active Since 04/25/2007
- Last Updated 09/09/2010
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1871712083
Products in Payments
- Vemlidy (Drug) $125.00
- ELITEK (Biological) $99.95
- SARCLISA (Biological) $89.11
- ZEJULA (Drug) $75.45
- ZALTRAP (Drug) $74.99
- ELIQUIS (Drug) $45.16
- Padcev (Drug) $32.92
- OPDIVO (Biological) $31.91
- XARELTO (Drug) $29.67
- ERLEADA (Drug) $25.16
- Lonsurf (Drug) $23.38
- Rubraca (Drug) $22.17
- TIVDAK (Biological) $20.47
- CHANTIX (Drug) $19.71
- Epic Stented Tissue Valve (Device) $19.41
- TECENTRIQ (Biological) $18.59
- Revlimid (Drug) $17.82
- Aranesp (Biological) $17.70
- LYNPARZA (Drug) $17.33
- Avastin (Biological) $17.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.